These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 7997543
61. Radionuclide tracers in the evaluation of resting myocardial ischaemia and viability. Opie LH, Hesse B. Eur J Nucl Med; 1997 Sep; 24(9):1183-93. PubMed ID: 9283116 [Abstract] [Full Text] [Related]
62. [The myocardium at risk in transient ischemia: its assessment by nuclear imaging]. Galli M, Marcassa C, Giordano A. G Ital Cardiol; 1993 Apr; 23(4):423-31. PubMed ID: 8319871 [No Abstract] [Full Text] [Related]
64. [Evaluation of necrosis and viability of myocardium after acute myocardial infarction, and risk stratification by nuclear method]. Mitani I. Nihon Rinsho; 2003 May; 61 Suppl 5():409-14. PubMed ID: 12808977 [No Abstract] [Full Text] [Related]
65. Heterogeneity of myocardial perfusion provides the physiological basis of perfusable tissue index. Herrero P, Staudenherz A, Walsh JF, Gropler RJ, Bergmann SR. J Nucl Med; 1995 Feb; 36(2):320-7. PubMed ID: 7830138 [Abstract] [Full Text] [Related]
66. Assessment of myocardial viability by use of multiple clinical parameters and effect on prognosis. Tamaki N. Coron Artery Dis; 1993 Jun; 4(6):521-8. PubMed ID: 8261230 [No Abstract] [Full Text] [Related]
67. Assessment of myocardial infarction with three radiotracers. Bianco JA. J Nucl Med; 1991 Dec; 32(12):2360-1. PubMed ID: 1744728 [No Abstract] [Full Text] [Related]
71. Combined evaluation of perfusion and function for the identification of viable myocardium. Giubbini R, Milan E, Rossini PL, Alfieri O, Ferrari R, Metra M, La Canna G. J Nucl Biol Med (1991); 1992 Apr; 36(2 Suppl):126-9. PubMed ID: 1450235 [No Abstract] [Full Text] [Related]
72. FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: for. Bax JJ. Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):829-31. PubMed ID: 15912400 [No Abstract] [Full Text] [Related]
73. Intramyocardial Gene Therapy Directed to Hibernating Heart Muscle Using a Combination of Electromechanical Mapping and Positron Emission Tomography. Hassinen I, Kivelä A, Hedman A, Saraste A, Knuuti J, Hartikainen J, Ylä-Herttuala S. Hum Gene Ther; 2016 Oct; 27(10):830-834. PubMed ID: 27553362 [Abstract] [Full Text] [Related]
74. [Radionuclide imaging of myocardial necrosis and viability]. Mitani I, Nishimura T. Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):626-30. PubMed ID: 12440036 [No Abstract] [Full Text] [Related]
75. Quantitative 82Rb dynamic pet perfusion analysis with kinetic modeling for myocardial viability: Can we get away with just 82Rb perfusion kinetics? Ananthasubramaniam K, Arumugam P. J Nucl Cardiol; 2019 Apr; 26(2):387-390. PubMed ID: 30809756 [No Abstract] [Full Text] [Related]
76. [The identification of the hibernating myocardium by the study of the changes in the contractile function induced by pharmacological stress]. Bolognese L, Sarasso G, Rossi L, Rizzotti M, Sacchetti G, Bongo AS, Dellavesa P, Inglese E, Rossi P. G Ital Cardiol; 1993 May; 23(5):527-31. PubMed ID: 8339879 [No Abstract] [Full Text] [Related]
77. Silent myocardial ischemia during PET. Nagy B, Grella R, Garza D, Van Tosh A, Horowitz SF. J Nucl Med; 1995 Jun; 36(6):1034-6. PubMed ID: 7769423 [Abstract] [Full Text] [Related]
78. Hibernating myocardium, a clinical entity. Flameng W, Shivalkar B. Basic Res Cardiol; 1995 Jun; 90(1):55-7. PubMed ID: 7779063 [No Abstract] [Full Text] [Related]
79. [Myocardial tissue characterization by using ultrafast x-ray computed tomography]. Naito H, Takamiya M. Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):437-41. PubMed ID: 12436561 [No Abstract] [Full Text] [Related]
80. Is nuclear medicine viable and can it measure viability? Nunn AD. J Nucl Med; 1993 Jun; 34(6):924-6. PubMed ID: 8509859 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]